XBI

SPDR S&P BIOTECH ETF
CLOSING PRICECHANGE (%)VOLUME
$80.77+0.63 (0.79%)3.23M
4:00:00 p.m. (ET) 07/21/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------
A

44
  • Overview
  • Efficiency
  • Tradability
  • Fit

XBI Fund Description

The SPDR S&P Biotech ETF tracks an equal-weighted index of US biotechnology stocks.

XBI FactSet Analytics Insight

XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap as we see it. This highly efficient fund, which charges less than competing funds, has a history of beating its index due to revenue from securities lending. It has attracted a large asset base and trades with excellent volume. The fund’s alternative take on the space earns it a place on our Opportunities List.

XBI MSCI ESG Fund metrics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of July 20, 2017 the SPDR S&P BIOTECH ETF MSCI ESG Fund Quality Score is 4.09 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. XBI ranks in the 7th percentile within its peer group and in the 11st percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

XBI Top 10 Countries

XBI Top 10 Sectors

XBI Top 10 Holdings View All

XBI Summary Data

01/31/06
Open-Ended Fund
0.35%
$3.89 B
$335.25 M
0.04%

XBI Portfolio Data

$15.78 B
-20.09
6.13
0.22%
09/15/17
96

XBI Index Data

Equal
Market Cap
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to XBI

FBT, BBP, CNCR, BBC
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

XBI Portfolio Management

0.35%
0.17%
0.36%
-0.20%

XBI Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XBI Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:59:5980.7780
15:59:5980.7666
15:59:5980.7634
15:59:5980.75100
15:59:5980.75100
15:59:5980.7533
15:59:5980.75100
15:59:5880.7492
15:59:5880.74100
15:59:5880.74200
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

XBI FactSet Analytics Block Liquidity

As of 07/21/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XBI. XBI is rated a 5 out of 5.

XBI Tradability

4,485,567
$335.25 M
4,325,321
$313.0 M
0.04%
$0.03
-0.01%
0.23% / -0.72%
None
100.00%
50,000
86.51
0.01%
0.13%
392,379
$80.14
5

XBI Performance Statistics

0.82
1.33
1.27
1.28
0.81%
Thomson Reuters US Biotechnology & Medical Research

XBI MSCI ESG Fund Metrics

4.09 / 10
7.45
10.57
1.69%
19.23%
23.78